(Q40136117)

English

Pluronic F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery of Bordetella bronchiseptica antigens containing dermonecrotoxin

scientific article published on 9 April 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Pluronic F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery of Bordetella bronchiseptica antigens containing dermonecrotoxin (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1 reference

based on heuristic

inferred from title

Bordetella bronchiseptica

object named as

Bordetella bronchiseptica

1 reference

based on heuristic

inferred from title

author name string

Mi Lan Kang

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Hu-Lin Jiang

2

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Sang Gyun Kang

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Ding Ding Guo

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Deog Yong Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Chong-Su Cho

6

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Han Sang Yoo

7

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

language of work or name

0 references

publication date

9 April 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

4602-4610

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.038

7 January 2021

Absorption of polyethylene glycols 600 through 2000: the molecular weight dependence of gastrointestinal and nasal absorption

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.038

7 January 2021

Drug metabolism in the nasal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.038

7 January 2021

Nasal route and drug delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.038

7 January 2021

Chitosan--as a biomaterial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.038

7 January 2021

Chitosan as a novel nasal delivery system for vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.038

7 January 2021

Transport of nanoparticles across the rat nasal mucosa.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.038

7 January 2021

Evaluation of the clearance characteristics of bioadhesive systems in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.038

7 January 2021

Microspheres as nasal drug delivery systems.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.038

7 January 2021

Mucoadhesive microspheres for controlled drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.038

7 January 2021

Chitosan microspheres as a potential carrier for drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.038

7 January 2021

Nasal delivery of insulin using chitosan microspheres

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.038

7 January 2021

In vitro study of the immune stimulating activity of an atrophic [correction of athrophic] rhinitis vaccine associated to chitosan microspheres

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.038

7 January 2021

In vivo induction of mucosal immune responses by intranasal administration of chitosan microspheres containing Bordetella bronchiseptica DNT.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.038

7 January 2021

Controlled-release delivery system for the alpha-MSH analog melanotan-I using poloxamer 407.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.038

7 January 2021

Effect of surfactants on the physical stability of recombinant human growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.038

7 January 2021

Controlled release injectable liposomal gel of ibuprofen for epidural analgesia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.038

7 January 2021

Pluronic F127 gel formulations of deslorelin and GnRH reduce drug degradation and sustain drug release and effect in cattle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.038

7 January 2021

Virulence of Bordetella bronchiseptica from pigs with or without atrophic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.038

7 January 2021

Role of the dermonecrotic toxin of Bordetella bronchiseptica in the pathogenesis of respiratory disease in swine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.038

7 January 2021

Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.038

7 January 2021

Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.038

7 January 2021

Pluronic F127-based systemic vaccine delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.038

7 January 2021

The mucosal immune system: from fundamental concepts to vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.038

7 January 2021

Identifiers

10.1016/J.VACCINE.2007.03.038

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40136117&oldid=1886499862"